Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.63 |
| ▸ | TSHR | P16473 | 3/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | GFER | P55789 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.48 |
| ▸ | RELA | Q04206 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9461879 | 0.82 | GAA (0.62) | GAASMN1; SMN2TSHRALDH1A1MAPT | |
| SCHEMBL10942888 | 0.82 | CYP3A4 (0.68) | GAASMN1; SMN2TSHRCYP3A4ALOX5 | |
| SCHEMBL20984621 | 0.82 | GAA (0.62) | GAASMN1; SMN2TSHRALDH1A1MAPT | |
| SCHEMBL8743016 | 0.80 | KMT2A (0.68) | GAASMN1; SMN2TSHRCYP3A4ALOX5 | |
| SCHEMBL424604 | 0.80 | CYP3A4 (0.65) | GAASMN1; SMN2TSHRCYP3A4ALOX5 | |
| SCHEMBL2384404 | 0.78 | CYP3A4 (0.63) | GAASMN1; SMN2TSHRCYP3A4ALOX5 | |
| SCHEMBL1337003 | 0.78 | CYP3A4 (0.63) | GAASMN1; SMN2TSHRCYP3A4ALOX5 | |
| SCHEMBL14001690 | 0.78 | CYP3A4 (0.63) | GAASMN1; SMN2TSHRCYP3A4ALOX5 | |
| SCHEMBL8601895 | 0.78 | GAA (0.58) | GAASMN1; SMN2TSHRALDH1A1MAPT | |
| SCHEMBL8861401 | 0.78 | TSHR (0.63) | GAASMN1; SMN2TSHRCYP3A4ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7115676-B2 | Adhesive compositions for bonding passive substrates | HENKEL CORPORATION (US) | 2006-10-03 | — | — | US | claimed |
| US-20030217808-A1 | Adhesive compositions for bonding passive substrates | Henkel IP & Holding GmbH (DE) | 2003-11-27 | — | — | US | claimed |
| EP-1285037-A2 | ADHESIVE COMPOSITIONS FOR BONDING PASSIVE SUBSTRATES SUCH AS MAGNESIUM ALLOYS | Henkel Loctite Corporation (US) | 2003-02-26 | — | — | EP | claimed |
| WO-2001088050-A2 | ADHESIVE COMPOSITIONS FOR BONDING PASSIVE SUBSTRATES SUCH AS MAGNESIUM ALLOYS | HENKEL LOCTITE CORPORATION (US) | 2001-11-22 | — | — | WO | claimed |
| US-20260109883-A1 | ANAEROBIC ADHESIVE COMPOSITION | OKURA INDUSTRIAL CO LTD (JP) | 2026-04-23 | — | — | US | disclosed |
| EP-4714992-A1 | POLYTETRAMETHYLENE GLYCOL-BASED (METH)ACRYLATE COMPOUND | Cemedine Co., Ltd. (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-12460073-B2 | Curable resin composition, fuel cell, and sealing method | THREEBOND CO., LTD. (JP) | 2025-11-04 | — | — | US | disclosed |
| US-12325811-B2 | Radical-polymerizable adhesive composition for laminating and bonding steel plates, adhesive laminate, motor, and method for manufacturing adhesive laminate | THREEBOND CO., LTD. (JP) | 2025-06-10 | — | — | US | disclosed |
| CN-116377044-B | Methods and complexes for sequential translocation of two non-covalently bound complementary nucleic acid strands through a nanopore | 牛津纳米孔科技公开有限公司 | 2025-05-06 | — | — | CN | disclosed |
| WO-2025074830-A1 | ANAEROBIC ADHESIVE COMPOSITION FOR ELECTROMAGNETIC STEEL SHEET | 大倉工業株式会社 | 2025-04-10 | — | — | WO | disclosed |
| WO-2025057988-A1 | ANAEROBIC ADHESIVE COMPOSITION | 大倉工業株式会社 | 2025-03-20 | — | — | WO | disclosed |
| WO-2025052775-A1 | PHOTOCURABLE RESIN COMPOSITION | 株式会社スリーボンド | 2025-03-13 | — | — | WO | disclosed |
| WO-2007089031-A1 | PIPERIDINE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-08-09 | — | — | WO | disclosed |
| US-7115676-B2 | Adhesive compositions for bonding passive substrates | HENKEL CORPORATION (US) | 2006-10-03 | — | — | US | disclosed |
| US-20030217808-A1 | Adhesive compositions for bonding passive substrates | Henkel IP & Holding GmbH (DE) | 2003-11-27 | — | — | US | disclosed |
| EP-1285037-A2 | ADHESIVE COMPOSITIONS FOR BONDING PASSIVE SUBSTRATES SUCH AS MAGNESIUM ALLOYS | Henkel Loctite Corporation (US) | 2003-02-26 | — | — | EP | disclosed |
| WO-2001088050-A2 | ADHESIVE COMPOSITIONS FOR BONDING PASSIVE SUBSTRATES SUCH AS MAGNESIUM ALLOYS | HENKEL LOCTITE CORPORATION (US) | 2001-11-22 | — | — | WO | disclosed |
| US-4321349-A | Accelerator for curable compositions | LOCTITE CORPORATION (US) | 1982-03-23 | — | — | US | disclosed |
| US-4287330-A | Accelerator for curable compositions | LOCTITE CORPORATION (US) | 1981-09-01 | — | — | US | disclosed |
| US-4180640-A | HYDRAZIDE DERIVATIVES | LOCTITE CORPORATION (US) | 1979-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109883-A1 | ANAEROBIC ADHESIVE COMPOSITION | MAT2B, MAT1A, MMAB | GAA 3940/4885SMN1; SMN2 1119/4885TSHR 4826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.